Cargando…

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Ahn, Terrie S., Han, Brandon, Krogstad, Paul, Bun, Chantana, Kohn, Lisa A., Garcia-Lloret, Maria I., Damoiseaux, Robert, Butte, Manish J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833834/ https://www.ncbi.nlm.nih.gov/pubmed/33358557 http://dx.doi.org/10.1016/j.jaci.2020.12.003

Ejemplares similares

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study
por: Marasco, Vincenzo, et al.
Publicado: (2022)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Epidemiological characteristics of and containment measures for COVID-19 in Busan, Korea
por: Son, Hyunjin, et al.
Publicado: (2020)

Les immunoglobulines anti-COVID en pédiatrie, pour qui, pourquoi, comment ?
por: Mershati, S. El, et al.
Publicado: (2023)

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

The role of C-reactive protein as a prognostic marker in COVID-19
por: Stringer, Dominic, et al.
Publicado: (2021)

Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series
por: Kapoor, Rajan, et al.
Publicado: (2021)

Containing COVID-19 in a specialised neurology centre: the risks of presymptomatic transmission
por: Wee, Liang En Ian, et al.
Publicado: (2020)

Fitted containment efficiency of face masks for reducing emission of aerosols in the indoor environment
por: Bennett, William, et al.
Publicado: (2022)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

“Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis”
por: Sanjay, Srinivasan, et al.
Publicado: (2021)

Endothelial Cell–Activating Antibodies in COVID‐19
por: Shi, Hui, et al.
Publicado: (2022)

Depressive symptoms in higher education students during the COVID-19 pandemic: the role of containment measures
por: Buffel, Veerle, et al.
Publicado: (2022)

Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19
por: Kundura, Lucy, et al.
Publicado: (2022)

Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report
por: Patrocínio de Jesus, Rita, et al.
Publicado: (2020)

COVID-19 antibody seroprevalence in Santa Clara County, California
por: Bendavid, Eran, et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19
por: Cimolai, Nevio
Publicado: (2021)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
por: Chowdhury, Onima, et al.
Publicado: (2021)

Bell’s palsy following COVID-19 vaccination with high CSF antibody response
por: Obermann, Mark, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination
por: Mumoli, Laura, et al.
Publicado: (2021)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study
por: Espenhain, Laura, et al.
Publicado: (2021)

Possible Reactivation of SARS-CoV-2 in a Patient with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Case Report
por: Dalla Via, Vera, et al.
Publicado: (2021)

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Antimicrobial Stewardship-Driven Monoclonal Antibody Treatment Program for COVID-19 Patients in the Bronx, New York
por: Guo, Yi, et al.
Publicado: (2021)

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
por: Passamonti, Francesco, et al.
Publicado: (2021)

Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
por: Sauerwein, Kai M.T., et al.
Publicado: (2023)

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
por: Cervia, Carlo, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea
por: Yoon, Kyuhyun, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey
por: Kim, Ah-Ra, et al.
Publicado: (2022)

Prevalence and risk factors of SARS-CoV-2 antibody responses among healthcare workers (June 2020–November 2021)
por: Barrufet, Maria Pilar, et al.
Publicado: (2023)

Knowledge and identity antecedents of COVID-19 vaccine status: a study of South Carolina residents
por: MERCADO, BRANDON, et al.
Publicado: (2023)

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits
por: Nagasawa, Masayuki, et al.
Publicado: (2020)

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
por: Bellinvia, Angelo, et al.
Publicado: (2022)

The Impact of Quarantines, Lockdowns, and ‘Reopenings’ on the Commercialization of Science: Micro and Macro Issues
por: Siegel, Donald S., et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus
por: Kang, Minsung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0m45tqlins6noo5fj7rg4fpiv